SCM

Silverarc Capital Management Portfolio holdings

AUM $489M
1-Year Est. Return 71.55%
This Quarter Est. Return
1 Year Est. Return
+71.55%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$479M
AUM Growth
+$31.4M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
82
New
Increased
Reduced
Closed

Top Buys

1 +$12.5M
2 +$11.9M
3 +$10.3M
4
NBIX icon
Neurocrine Biosciences
NBIX
+$8.03M
5
IRON icon
Disc Medicine
IRON
+$6.26M

Top Sells

1 +$17.3M
2 +$15M
3 +$9.72M
4
SRRK icon
Scholar Rock
SRRK
+$7.92M
5
COGT icon
Cogent Biosciences
COGT
+$7.18M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VRNA
1
DELISTED
Verona Pharma
VRNA
$34.7M 7.09%
545,872
+29,858
MRUS icon
2
Merus
MRUS
$7.19B
$34.1M 6.98%
811,021
+130,176
NUVL icon
3
Nuvalent
NUVL
$6.52B
$31.1M 6.37%
439,018
+39,004
AKRO icon
4
Akero Therapeutics
AKRO
$4.3B
$29.1M 5.96%
719,992
-19,571
INSM icon
5
Insmed
INSM
$34.5B
$24.5M 5.01%
321,366
-50,864
KALV icon
6
KalVista Pharmaceuticals
KALV
$558M
$19.6M 4.01%
1,698,984
+1,086,811
VCYT icon
7
Veracyte
VCYT
$2.82B
$18.8M 3.84%
633,832
+130,551
RYTM icon
8
Rhythm Pharmaceuticals
RYTM
$7.38B
$17.9M 3.66%
337,605
+63,709
SNDX icon
9
Syndax Pharmaceuticals
SNDX
$1.3B
$16.1M 3.29%
1,309,224
+78,824
URGN icon
10
UroGen Pharma
URGN
$783M
$15.3M 3.12%
1,381,158
+260,685
RNA icon
11
Avidity Biosciences
RNA
$7.12B
$12.1M 2.48%
411,312
-132,339
SLNO icon
12
Soleno Therapeutics
SLNO
$3.61B
$11.9M 2.43%
+166,417
ASND icon
13
Ascendis Pharma
ASND
$12.5B
$11.8M 2.41%
75,751
+24,260
IRON icon
14
Disc Medicine
IRON
$2.59B
$11.7M 2.4%
236,471
+126,090
ORIC icon
15
Oric Pharmaceuticals
ORIC
$1.29B
$11.5M 2.35%
2,060,240
+881,940
ETNB icon
16
89bio
ETNB
$2.19B
$11M 2.25%
1,510,498
+1,413,987
ERAS icon
17
Erasca
ERAS
$718M
$10.1M 2.06%
7,367,996
-175,905
WVE icon
18
Wave Life Sciences
WVE
$1.25B
$8.49M 1.74%
1,050,374
+441,477
NBIX icon
19
Neurocrine Biosciences
NBIX
$13.6B
$8.03M 1.64%
+72,583
TVTX icon
20
Travere Therapeutics
TVTX
$2.45B
$7.33M 1.5%
408,849
+131,484
GOSS icon
21
Gossamer Bio
GOSS
$529M
$6.95M 1.42%
6,320,684
+148,837
GILD icon
22
Gilead Sciences
GILD
$146B
$6.95M 1.42%
62,029
+52,029
BBOT
23
BridgeBio Oncology
BBOT
$903M
$6.93M 1.42%
613,393
+100,024
ELUT icon
24
Elutia
ELUT
$38.2M
$6.76M 1.38%
2,670,056
+887,785
PRAX icon
25
Praxis Precision Medicines
PRAX
$3.42B
$6.29M 1.29%
166,074
+93,558